<?xml version="1.0" encoding="UTF-8"?>

<Library xmlns="http://hl7.org/fhir">
  <id value="HIVIND50Logic"/>
  <meta>
    <profile value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary"/>
    <profile value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary"/>
    <profile value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library"/>
    <profile value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Library HIVIND50Logic</b></p><a name="HIVIND50Logic"> </a><a name="hcHIVIND50Logic"> </a><a name="HIVIND50Logic-en-US"> </a><h2>Contents</h2><p><code>text/cql</code></p><pre><code class="language-sql">/**
 * Library: HIV.IND.50 Logic
 * Ref No: DFT.3
 * Short Name: TB testing among those symptom-screened positive
 *
 * Definition: % of people living with HIV newly initiated on ART and screened positive for TB symptoms who then are tested for TB
 *
 * Numerator: Number of people living with HIV newly initiated on ART who are investigated for active TB disease with appropriate diagnostic testing*
 * Numerator Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND with &quot;ART start type&quot;='First-time user of ART' AND with &quot;ART start date&quot; in the reporting period AND &quot;TB screening date&quot; in the reporting period AND &quot;TB screening result&quot;='Screen positive for TB' AND a &quot;TB diagnostic test category&quot; is NOT NULL AND with a &quot;TB diagnostic test date&quot; in the reporting period
 * Numerator Exclusions: 
 *
 * Denominator: Number of people living with HIV newly initiated on ART and screened positive for TB symptoms during the reporting period
 * Denominator Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND with &quot;ART start type&quot;='First-time user of ART' AND with &quot;ART start date&quot; in the reporting period AND &quot;TB screening date&quot; in the reporting period AND &quot;TB screening result&quot;='Screen positive for TB'
 * Denominator Exclusions: 
 *
 * Disaggregations:
 * • Gender (male, female, other**) 
 *  • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–49, 50+ years)*** 
 *  • Cities and other administrative regions of epidemiologic importance 
 *   
 *  Consider disaggregating the type of diagnostic testing, for example, GeneXpert testing, LF-LAM, sputum acid-fast bacilli (AFB) examination (alone) or other diagnostic testing.
 *
 * Disaggregation Elements: Gender | Age | TB diagnostic test category
 *
 * Numerator and Denominator Elements:
 * ART start date 
 *  ART start type 
 *  HIV status 
 *  TB diagnostic test category 
 *  TB diagnostic test date 
 *  TB screening date 
 *  TB screening result
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.B.DE72: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.
 * HIV.B.DE116: HIV-positive | Client is HIV-positive
 * HIV.B.DE117: HIV-negative | Client is HIV-negative
 * HIV.B.DE118: Unknown | Client has unknown HIV status
 * HIV.D.DE39: ART start date | The date on which the client started or restarted ART
 * HIV.D.DE43: ART start type | Whether the client is ART naive or is restarting ART
 * HIV.D.DE44: First-time user of ART | Client is ART naive, having never taken ART to treat HIV before
 * HIV.D.DE45: Restarting ART | Client is restarting ART after stopping treatment for any reason
 * HIV.D.DE986: TB screening result | Record the result of the tuberculosis (TB) screening
 * HIV.D.DE987: Screen positive for TB | Screening result was positive for tuberculosis (TB)
 * HIV.D.DE988: Screen negative for TB | Screening result was negative for tuberculosis (TB)
 * HIV.D.DE989: Inconclusive | Screening result was inconclusive for tuberculosis (TB)
 * HIV.D.DE990: TB screening date | Date the TB screening was conducted
 * HIV.D.DE992: TB diagnostic test category | The type of diagnostic test performed to detect tuberculosis (TB) disease
 * HIV.D.DE993: LF-LAM | Client tested for tuberculosis with a lateral flow urine lipoarabinomannan assay
 * HIV.D.DE994: mWRD test for TB | Client tested with a WHO-recommended molecular diagnostic test to detect Mycobacterium tuberculosis (MTB)
 * HIV.D.DE995: Microscopy - Sputum acid-fast bacilli (AFB) | Client tested for tuberculosis with a sputum acid-fast bacilli (AFB)
 * HIV.D.DE996: TB Culture | Client tested for tuberculosis (TB) with a culture
 * HIV.D.DE997: TB diagnostic test date | The date when TB diagnostic test was performed
 * HIV.SRV.DE6: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 *
 * Additional Context
 * - what it measures: This indicator measures the percentage of people living with HIV newly initiated on ART and screened positive for TB symptoms who then had clinical evaluation and/or appropriate TB diagnostic testing.
 * - rationale: • Appropriate TB diagnostic testing is essential for people living with HIV who symptom- screen positive for TB. | • It is important to understand the cascade from ART enrolment to treatment of active | TB disease; this indicator will shed light on any obstacles between positive screening for TB symptoms and proper diagnostic testing, based on national clinical guidelines. | • This is the third of five &quot;screening cascade&quot; indicators considered priority for high burden TB/HIV settings.
 * - method: &quot;Newly initiated&quot; is defined as the number of people living with HIV who start ART in accordance with national treatment guidelines during the reporting period. |  | For the numerator and denominator: Programme records (for example, ART registers, EMR)
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND50Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include FHIRCommon called FC
include WHOCommon called WCom

// Indicator Definition
parameter &quot;Measurement Period&quot; Interval&lt;Date&gt; default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define &quot;Initial Population&quot;:
  true

/**
 * Numerator
 * 
 * Definition: Number of people living with HIV newly initiated on ART who are investigated for active TB disease with appropriate diagnostic testing*
 * Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND with &quot;ART start type&quot;='First-time user of ART' AND with &quot;ART start date&quot; in the reporting period AND &quot;TB screening date&quot; in the reporting period AND &quot;TB screening result&quot;='Screen positive for TB' AND a &quot;TB diagnostic test category&quot; is NOT NULL AND with a &quot;TB diagnostic test date&quot; in the reporting period
 */

define &quot;Numerator&quot;:
  true


/**
 * Denominator
 *
 * Definition: Number of people living with HIV newly initiated on ART and screened positive for TB symptoms during the reporting period
 * Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND with &quot;ART start type&quot;='First-time user of ART' AND with &quot;ART start date&quot; in the reporting period AND &quot;TB screening date&quot; in the reporting period AND &quot;TB screening result&quot;='Screen positive for TB'
 */

define &quot;Denominator&quot;:
  true
    

/* end Populations */

</code></pre><p><code>No Content</code> (<code>application/elm+xml</code>)</p></div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <url value="http://smart.who.int/HIV/Library/HIVIND50Logic"/>
  <version value="0.2.0"/>
  <name value="HIVIND50Logic"/>
  <title value="HIV.IND.50 Logic"/>
  <status value="draft"/>
  <experimental value="true"/>
  <type>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/library-type"/>
      <code value="logic-library"/>
    </coding>
  </type>
  <date value="2024-08-06T17:04:54+00:00"/>
  <publisher value="WHO"/>
  <contact>
    <name value="WHO"/>
    <telecom>
      <system value="url"/>
      <value value="http://who.int"/>
    </telecom>
  </contact>
  <description value="% of people living with HIV newly initiated on ART and screened positive for TB symptoms who then are tested for TB"/>
  <content>
    <contentType value="text/cql"/>
    <data value="/**
 * Library: HIV.IND.50 Logic
 * Ref No: DFT.3
 * Short Name: TB testing among those symptom-screened positive
 *
 * Definition: % of people living with HIV newly initiated on ART and screened positive for TB symptoms who then are tested for TB
 *
 * Numerator: Number of people living with HIV newly initiated on ART who are investigated for active TB disease with appropriate diagnostic testing*
 * Numerator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period
 * Numerator Exclusions: 
 *
 * Denominator: Number of people living with HIV newly initiated on ART and screened positive for TB symptoms during the reporting period
 * Denominator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB'
 * Denominator Exclusions: 
 *
 * Disaggregations:
 * • Gender (male, female, other**) 
 *  • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–49, 50+ years)*** 
 *  • Cities and other administrative regions of epidemiologic importance 
 *   
 *  Consider disaggregating the type of diagnostic testing, for example, GeneXpert testing, LF-LAM, sputum acid-fast bacilli (AFB) examination (alone) or other diagnostic testing.
 *
 * Disaggregation Elements: Gender | Age | TB diagnostic test category
 *
 * Numerator and Denominator Elements:
 * ART start date 
 *  ART start type 
 *  HIV status 
 *  TB diagnostic test category 
 *  TB diagnostic test date 
 *  TB screening date 
 *  TB screening result
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.B.DE72: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.
 * HIV.B.DE116: HIV-positive | Client is HIV-positive
 * HIV.B.DE117: HIV-negative | Client is HIV-negative
 * HIV.B.DE118: Unknown | Client has unknown HIV status
 * HIV.D.DE39: ART start date | The date on which the client started or restarted ART
 * HIV.D.DE43: ART start type | Whether the client is ART naive or is restarting ART
 * HIV.D.DE44: First-time user of ART | Client is ART naive, having never taken ART to treat HIV before
 * HIV.D.DE45: Restarting ART | Client is restarting ART after stopping treatment for any reason
 * HIV.D.DE986: TB screening result | Record the result of the tuberculosis (TB) screening
 * HIV.D.DE987: Screen positive for TB | Screening result was positive for tuberculosis (TB)
 * HIV.D.DE988: Screen negative for TB | Screening result was negative for tuberculosis (TB)
 * HIV.D.DE989: Inconclusive | Screening result was inconclusive for tuberculosis (TB)
 * HIV.D.DE990: TB screening date | Date the TB screening was conducted
 * HIV.D.DE992: TB diagnostic test category | The type of diagnostic test performed to detect tuberculosis (TB) disease
 * HIV.D.DE993: LF-LAM | Client tested for tuberculosis with a lateral flow urine lipoarabinomannan assay
 * HIV.D.DE994: mWRD test for TB | Client tested with a WHO-recommended molecular diagnostic test to detect Mycobacterium tuberculosis (MTB)
 * HIV.D.DE995: Microscopy - Sputum acid-fast bacilli (AFB) | Client tested for tuberculosis with a sputum acid-fast bacilli (AFB)
 * HIV.D.DE996: TB Culture | Client tested for tuberculosis (TB) with a culture
 * HIV.D.DE997: TB diagnostic test date | The date when TB diagnostic test was performed
 * HIV.SRV.DE6: ART start date | The date on which the client started or restarted antiretroviral therapy (ART)
 *
 * Additional Context
 * - what it measures: This indicator measures the percentage of people living with HIV newly initiated on ART and screened positive for TB symptoms who then had clinical evaluation and/or appropriate TB diagnostic testing.
 * - rationale: • Appropriate TB diagnostic testing is essential for people living with HIV who symptom- screen positive for TB. | • It is important to understand the cascade from ART enrolment to treatment of active | TB disease; this indicator will shed light on any obstacles between positive screening for TB symptoms and proper diagnostic testing, based on national clinical guidelines. | • This is the third of five "screening cascade" indicators considered priority for high burden TB/HIV settings.
 * - method: "Newly initiated" is defined as the number of people living with HIV who start ART in accordance with national treatment guidelines during the reporting period. |  | For the numerator and denominator: Programme records (for example, ART registers, EMR)
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND50Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include FHIRCommon called FC
include WHOCommon called WCom

// Indicator Definition
parameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define "Initial Population":
  true

/**
 * Numerator
 * 
 * Definition: Number of people living with HIV newly initiated on ART who are investigated for active TB disease with appropriate diagnostic testing*
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB' AND a "TB diagnostic test category" is NOT NULL AND with a "TB diagnostic test date" in the reporting period
 */

define "Numerator":
  true


/**
 * Denominator
 *
 * Definition: Number of people living with HIV newly initiated on ART and screened positive for TB symptoms during the reporting period
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND with "ART start type"='First-time user of ART' AND with "ART start date" in the reporting period AND "TB screening date" in the reporting period AND "TB screening result"='Screen positive for TB'
 */

define "Denominator":
  true
    

/* end Populations */

"/>
  </content>
  <content>
    <contentType value="application/elm+xml"/>
  </content>
</Library>